RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Kincell Bio announced the completion of a $22 million round, led by a new investor, NewSpring Capital through its dedicated healthcare strategy, ...

Pete Buzy serves as a board member for Kincell Bio, bringing more than 25 years of executive leadership experience in life sciences and advanced therapy manufacturing. He is currently an Advisory ...

Agentic AI platform serves one-third of top 30 global pharma companies, delivering 18x faster insights and turning medical evidence into a driver for physician and patient adoption of novel therapies ...

NewSpring Health Capital and Veronis Suhler Stevenson (VSS) announced the completion of an investment in BRC Recovery Family of Programs (BRC). BRC, based in Austin, Texas, provides treatments to ...

RADNOR, Pa., Aug. 5, 2021 /PRNewswire/ -- NewSpring (the "Firm"), a family of private equity strategies, today announced the final close of its fourth mezzanine fund, NewSpring Mezzanine Capital IV ...